The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and ...

A new large-scale study conducted by the Cleveland Clinic on the effectiveness of the 2024–2025 influenza vaccine shows that ...

Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...

The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B. “The FDA anticipates that there will be an ...

The global influenza vaccine market, valued at US$ 8.78 billion in 2023, is poised for remarkable growth, with projections indicating it will reach US$ 22.71 billion by 2032. This growth, representing ...

Trivalent egg-based A/Thailand/8/2022 (H3N2 ... Sino Biological unveils comprehensive Influenza research reagents for 2025–2026 vaccine strains Sino Biological, a leading provider of biological ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, and serological analyses. On February 28, 2025, WHO announced the ...

Vaccine development: Used in potency testing, ELISA-based antibody level analysis, and quality control. Research acceleration: Replace traditional viral culture methods, shortening R&D timelines. IV.

“The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal influenza vaccines” for the upcoming virus season, it said in a statement.There are ...